Mumper et al.Pharmaceutical Res., vol. 13, 5, pp. 701-709, 1996. |
Kabanov et al., Biopolymers, 1991, 31/12, 1437-1443. |
Monsigny et al., Ad. Drug Delivery Reviews, 14:1-24, 1994. |
Ledley, Hum. Gene. Ther., 6: 1129-1144, 1995. |
Kuo et al., Critical Reviews in Eukaryotic Expression 6, 1: 59-73, 1996. |
Salzman et al., Critical Reviews in Eukaryotic Gene Expression, vol. 6, 1, pp. 59-73, 1996. |
Monsigny et al., Advanced Drug Delivery Reviews, vol. 14, pp. 1-24, 1994. |
Petrak, Pharmaceutical Particulate Carriers, 1993, pp. 275-293. |
Hung et al., Gene Therapy, vol. 1, 1: pp. 64-69, 1994. |
Ledley (1995) Human Gene Therapy 6: 1129-1144. |
Papisov (1995) Adv. Drug Del. Rev. 16: 127-139. |
Ewel et al. (1992) Cancer Research 52: 3005-3010. |
Biswas et al. (1994) Journal of Biotechnology 32: 1-10. |
Szoka et al. (1993) Bioconjugate Chem. 4, 372-379. |
Duncan et al. (1992) Anti Cancer Drugs, 3: 175-210. |
Park et al. (1993) Advanced Drug Delivery Reviews, 11: 59-84. |
Bennett et al., "Inhibition of Vascular Smooth Muscle Cell Proliferation in Vitro and in Vivo by c-myc Antisense Oligodeoxynucleotides," J. Clin. Invest. 93(2):820-828 (1940). |
Caso et al., "Transfection in Micromonospora spp.," Applied and Environmental Microbiology 53(10):2544-2547 (1987). |
Chemla et al., "Effects of Antisense Oligonucleotides on Myointimale Hyperplasia in a Model of Abdominal Aortic Trauma in the Rat," Archives des Maladies Due Coeur Et Des Vaisseaux 88(3):381-389 (1995). |
Curiel et al., "High-Efficiency Gene Transfer Mediated by Adenovirus Coupled to DNA-Polylysine Complexes," Human Gene Therapy 3:147-154 (1992). |
"Reporter System Using Chloramphenicol Acetyltransferase," in Current Protocols in Molecular Biology, Supplement 29, Chapter 9, Unit 9.6A, pp. 9.6.5-9.6.6 (1993). |
Davis et al., "Direct Gene Transfer into Skeletal Muscle In Vivo: Factors Affecting Efficiency of Transfer and Stability of Expression," Human Gene Therapy 4:151-159 (1993). |
Edelman et al., "c-myc in Vasculoproliferative Disease," Circulation Research 76(2):176-182 (1995). |
Felgner et al., "Lipofection: A Highly Efficient, Lipid-mediated DNA-transfection Procedure," Proc. Natl. Acad. Sci. USA 84:7413-7417 (1987). |
Fraley et al., "Introduction of Liposome Encapsulated SV40 DNA into Cells," J. Biol. Chem. 225(21):10431-10435 (1980). |
Fulton et al., "Luminescent Reporter Gene Assays for Luciferase and .mu.-Galactosidase Using a Liquid Scintillation Counter," BioTechniques 14(5):762-763 (1993). |
Jain and Magrath, "A Chemiluminescent Assays for Quantitation of .mu.Galactosidase in the Femtogram Range: Application of Quantitation of .mu.-Galactosidase in lacZ-Transfected Cells," Analytical Biochemistry 199:119-124 (1991). |
Klebe et al., "Uptake by Cells of Nucleic Acids Promoted by Compounds Sharing the Pleiotropic Effects of Poly(Ethylene Glycol)," Teratogenesis, Carcinogenesis and Mutagenesis 6(3):245-250 (1986). |
March et al., "Facilitation of Adenoviral Gene Delivery by Poloxamer 407," Proceed. Intern. Symp. Control. Rel. Bioact. Mater. 21:348 (1994). |
Mumper et al., "Interactive Polymeric Gene Delivery Systems for Enhanced Muscle Expression," Pharmaceutical Research 12(9):S80 at abstract 2005 (1995). |
Nguyen et al., "Firefly Luciferase Luminescence Assays Using Scintillation Counters for Quantitation in Transfected Mammalian Cells," Analytical Biochemistry 171:404-408 (1988). |
Shaper et al., "Male Germ Cell Expression of Murine .mu.4-Galactosylatransferase: A 796-base pair genomic region containing two cAMP-responsive elements (CRE)-like elements, mediates expression in transgenic mice," J. Biol. Chem. 269:25165-25171 (1994). |
Uglea and Dumitru-Medvichi, "Ch. 15--Medical Applications of Synthetic Oligomers," in Polymeric Biomaterials, edited by Severian Dumitriu, Marcel Dekker, Inc., New York, pp. 725-747 (1994). |
U.S. Application No. 07/913,669, filed Jul. 14, 1992. |
Wagner et al., "Transferrin-polycation Conjugates as Carriers for DNA Uptake Into Cells," Proc. Natl. Acad. Sci. USA 87:3410-3414 (1990). |
Weith et al., "Synthesis of Cellulose Derivatives Containing the Dihydropxyboryl Group and a Study of Their Capacity to Form Specific Complexes with Sugars and Nucleic Acid Components," Biochemistry 9(22):4396-4401 (1970). |
Young et al., "Selective Inactivation of Eukaryotic .mu.-Galactosidase in Assays for Inhibitors of HIV-1 TAT Using Bacterial .mu.-Galactosidases as a Reporter Enzyme," Analytical Biochemistry 215:24-30 (1993). |